Neuroendocrine perturbations as a cause of insulin resistance.
about
Do stress reactions cause abdominal obesity and comorbidities?Chronic intermittent psychological stress promotes macrophage reverse cholesterol transport by impairing bile acid absorption in mice.The appraisal of chronic stress and the development of the metabolic syndrome: a systematic review of prospective cohort studiesNeurohormonal and inflammatory hyper-responsiveness to acute mental stress in depressionHypertension and the metabolic syndrome: closely related central origin?Sex differences in type 2 diabetes: focus on disease course and outcomesNonhuman primates and other animal models in diabetes research.Perinatal origin of adult disease.Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases.Association of cortisol and the metabolic syndrome in Korean men and womenMonocyte chemoattractant protein 1 in obesity and insulin resistance.Gender difference in adrenal sensitivity to ACTH is abolished in type 2 diabetes.High prevalence of type 2 diabetes and pre-diabetes in adult Zoroastrians in Yazd, Iran: a cross-sectional study.Type 2 diabetes-an introduction to the development and use of animal models.Association between the metabolic syndrome and serum cortisol in overweight Latino youth.Stress, the endoplasmic reticulum, and insulin resistance.Impact of psychological stress on the associations between apolipoprotein E variants and metabolic traits: findings in an American sample of caregivers and controls.High frequency of metabolic syndrome in adult Zoroastrians in Yazd, Iran: a cross-sectional studyDoes caring for a spouse with dementia promote cognitive decline? A hypothesis and proposed mechanisms.Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha.Relation of adiposity and body fat distribution to body mass index in Australians of Aboriginal and European ancestry.Examining the mediating roles of binge eating and emotional eating in the relationships between stress and metabolic abnormalities.Global and Targeted Metabolomics Evidence of the Protective Effect of Chinese Patent Medicine Jinkui Shenqi Pill on Adrenal Insufficiency after Acute Glucocorticoid Withdrawal in RatsInsulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo.Treatment of abdominally obese men with a serotonin reuptake inhibitor: a pilot study.Predictors of insulin sensitivity in Type 2 diabetes mellitus.Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients.Low high-density lipoprotein-cholesterol is the most prevalent metabolic abnormality for Australian Aboriginal men and women even when lean.Effects of Tai Chi and resistance training on cardiovascular risk factors in elderly Chinese subjects: a 12-month longitudinal, randomized, controlled intervention study.Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.Effects of hyperlipidaemia on glucocorticoid metabolism: results of a randomized controlled trial in healthy young women.The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men.Independent and combined associations of abdominal obesity and seated resting heart rate with type 2 diabetes among older Chinese: the Guangzhou Biobank Cohort Study
P2860
Q22250952-B29B6689-3359-46CE-97C3-C753BA118803Q30409183-F1F92946-F6D9-42CE-83CB-2ABAA2BF9528Q33629492-1D8F17D7-0FF1-42FB-AB5C-88A00414A194Q33872507-B0C50CF2-0DD0-448F-BA47-78623867CA7EQ33944081-240ADCA8-41E5-411D-8990-09DE6687A267Q34229975-0EA6137F-3A77-4562-B241-623387429C96Q34286456-DF1C5DD2-6DBF-4E1C-867A-0DC2C105390AQ34342513-3AD88CBE-EE66-4987-9463-C842832BF6A5Q34597334-0846EBDA-A88E-4166-A0B0-8114E134FA0FQ35072552-EBA27B54-5A72-47F6-8F10-06B5F67F2248Q35163496-E2EC1846-2DDC-4279-A8AD-7D10CB635D23Q35458184-3F325C35-24AC-4014-96F0-3B2387AFB112Q35682467-4CAB970C-3DE5-4C2A-9B4E-ACB0BC0FB3F7Q36521093-238C1AD9-3F7B-4A51-9301-8C65954B2402Q36536802-DCB131E7-F71F-4A6E-9E4E-F1A9EDC2ABF0Q36674827-EDC37417-F591-4B5C-8743-B497F734941AQ36763701-6C8FD81A-6AF5-4560-A52A-7B684569E263Q37149261-3228CDF4-5C22-4B46-96BC-E1D33D184CABQ37875192-D40D1966-9A3D-4DC8-90B3-33BF3F66E66FQ38349579-C1950EB1-1616-48A5-9F69-48853CADCACBQ39655747-ABB811C5-2B6C-4963-BE0A-097E2BA2B8E5Q40190286-5CA4E6E5-656F-46D7-B058-6B1CCB1F8529Q41689358-C933338D-7910-4B76-A1B3-FC73845B0301Q42499996-CCCFBED1-971F-4DB6-B4FB-4BB05330426EQ43736096-55E2755C-31E3-453E-81EF-9772DA09A641Q44051661-F02A1091-2C00-488C-99F1-B296BE988262Q46657362-78D47374-CAD2-4B76-B985-22A060AF9589Q46752234-15658D41-F21A-4A4D-B2FB-2D4EDB4D01BAQ46846753-9ACEED82-26C5-4581-8D78-9D97B035CE62Q46951311-11382151-54E4-4436-9C6B-30CCD2B65861Q52896531-3803D110-F042-49A5-84A8-1C687D83DDC7Q54030843-86912FE6-BBB2-4F87-8AD5-2908E590E0C0Q57556010-EB66F3B6-D1B0-4067-85AF-DBD805313F0B
P2860
Neuroendocrine perturbations as a cause of insulin resistance.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Neuroendocrine perturbations as a cause of insulin resistance.
@ast
Neuroendocrine perturbations as a cause of insulin resistance.
@en
type
label
Neuroendocrine perturbations as a cause of insulin resistance.
@ast
Neuroendocrine perturbations as a cause of insulin resistance.
@en
prefLabel
Neuroendocrine perturbations as a cause of insulin resistance.
@ast
Neuroendocrine perturbations as a cause of insulin resistance.
@en
P1476
Neuroendocrine perturbations as a cause of insulin resistance.
@en
P304
P356
10.1002/(SICI)1520-7560(199911/12)15:6<427::AID-DMRR68>3.0.CO;2-C
P577
1999-11-01T00:00:00Z